<?xml version="1.0" encoding="UTF-8"?>
<p>Studies of biological properties of PolyI: PolyC, started in the 1970s, showed that the drug was a powerful activator of innate immunity and an inducer of tumor cell apoptosis [
 <xref ref-type="bibr" rid="CR44">44</xref>]. Promising results have been obtained in clinical studies of PolyI:PolyC as a means of treating seasonal influenza [
 <xref ref-type="bibr" rid="CR71">71</xref>], as well as treating malignant tumors of different localizations in adults and children [
 <xref ref-type="bibr" rid="CR72">72</xref>â€“
 <xref ref-type="bibr" rid="CR74">74</xref>].
</p>
